Pacira Pharm Inc (PCRX)
$14.84
0.15 (0.99%)
PCRX Stock Quote Delayed 30 Minutes
PCRX Stock Earnings: Pacira BioSciences Beats EPS, Beats Revenue for Q2 2024
PCRX stock results show that Pacira BioSciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
659.49M
PE Ratio
11.15
EPS
1.33
Volume (Avg. Vol.)
1.05M
Day's Range
$14.58 - $15.15
52-Week Range
$11.16 - $35.95
Dividend & Yield
N/A (N/A)
PCRX Stock Predictions, Articles, and Pacira Pharm Inc News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, traders! We're kicking off the week right with a look at the biggest pre-market stock market movers for Monday!
OK Boomer, Flexion Stock Is Made For You
FLXN stock has been falling because the company is not in the race for a Covid-19 vaccine. But as that field narrows, FLX is worth a look.
Flexion Therapeutics Inc (FLXN) Stock Soars on Possible Sale to Sanofi
Flexion (FLXN) may soon be acquiring Sanofi (SNY) to boost its arthritis medications portfolio. Here's what you should know about the deal.
Hottest Manufacturing Stocks Now – SPCB CALA MTP OCRX
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – PTLA DPRX SGYP BIOA
The following stocks were moving the Manufacturing sector today.
Hottest Manufacturing Stocks Now – PTLA BIOA CRME FLXN
The following stocks were moving the Manufacturing sector today.
40 Biotechnology Stocks to Sell Now
This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
11 Pharmaceuticals Stocks to Sell Now
The overall ratings of 11 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
40 Biotechnology Stocks to Sell Now
The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
16 Pharmaceuticals Stocks to Sell Now
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – RDUS ATRA RARE CMCO
The following stocks were moving the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – CRDS CLLS FOSL CARA
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
14 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 14 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
8 Biotechnology Stocks to Buy Now
This week, 8 Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Hottest Manufacturing Stocks Now – RELV IIN LMT ZGNX
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Hottest Manufacturing Stocks Now – EBIO VYGR DMTX LPTN
The following stocks were moving the Manufacturing sector today.
Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!
Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.
